Dr. Linenberger is the local principal investigator on a multicenter study of hematopoietic stem cell donor safety and quality of life, sponsored by the Center for International Blood and Marrow Transplant Research. In his role as Medical Director of Cellular Therapy and Apheresis, Dr. Linenberger supports the activities of the Cell Processing Core of the Fred Hutchinson Cancer Research Center (FHCRC), which provides critical instrumentation and technical expertise for the procurement, characterization and processing of all clinical cellular components necessary for the treatment of patients and for correlative research studies. These activities support the investigational protocols that utilize the Cellular Processing Facility (a GMP production laboratory) and a research specimen repository.
Seattle Cancer Care AllianceBox 358081, FHCRC Mailstop D5-2801100 Fairview Avenue NorthSeattle, WA 98109
Safe and effective management of patients and donors undergoing marrow harvest and peripheral blood stem cell mobilization and collection by apheresis
Hematologic malignancies, benign hematologic disorders, bleeding and thrombotic disorders, therapeutic apheresis and stem cell procurement